Starr JA - Search Results

1

The Impact of SGLT2 Inhibitors on Cardiovascular Outcomes in Patients With Heart Failure With Preserved Ejection Fraction.

Starr JA, Pinner NA. Starr JA, et al. Ann Pharmacother. 2024 May;58(5):506-513. doi: 10.1177/10600280231189508. Epub 2023 Aug 5. Ann Pharmacother. 2024. PMID: 37542422 Review.

2

Role of tissue plasminogen activator in acute ischemic stroke.

Hatcher MA, Starr JA. Hatcher MA, et al. Among authors: starr ja. Ann Pharmacother. 2011 Mar;45(3):364-71. doi: 10.1345/aph.1P525. Epub 2011 Mar 8. Ann Pharmacother. 2011. PMID: 21386027 Review.

3

Timing of Anticoagulation in Atrial Fibrillation Status Post Cardioembolic Stroke.

Core A, Pinner N, Bethea B, Starr JA. Core A, et al. Among authors: starr ja. J Pharm Pract. 2020 Oct;33(5):612-617. doi: 10.1177/0897190019825577. Epub 2019 Jan 31. J Pharm Pract. 2020. PMID: 30704323

4

Frequency of β-Blocker Use Following Exacerbations of COPD in Patients with Compelling Indication for Use.

Pinner N, Oliver W, Veasey T, Starr J, Eudaley S, Hutchison A, Wargo K. Pinner N, et al. South Med J. 2019 Nov;112(11):586-590. doi: 10.14423/SMJ.0000000000001038. South Med J. 2019. PMID: 31682740

5

Impact of SGLT2 inhibitors on cardiovascular outcomes in patients with heart failure with reduced ejection fraction.

Starr JA, Pinner NA, Lisenby KM, Osmonson A. Starr JA, et al. Pharmacotherapy. 2021 Jun;41(6):526-536. doi: 10.1002/phar.2527. Epub 2021 Apr 29. Pharmacotherapy. 2021. PMID: 33866578 Review.

6

A Review of Direct Oral Anticoagulants in Patients With Stage 5 or End-Stage Kidney Disease.

Starr JA, Pinner NA, Mannis M, Stuart MK. Starr JA, et al. Ann Pharmacother. 2022 Jun;56(6):691-703. doi: 10.1177/10600280211040093. Epub 2021 Aug 29. Ann Pharmacother. 2022. PMID: 34459281 Review.

7

Safety of Nonvitamin K Antagonists Compared with Warfarin in Patients with Atrial Fibrillation and End-Stage Kidney Disease.

Pinner NA, Osmonson AJ, Starr JA. Pinner NA, et al. Among authors: starr ja. South Med J. 2022 Oct;115(10):794-798. doi: 10.14423/SMJ.0000000000001453. South Med J. 2022. PMID: 36191918

8

Dual Antiplatelet Therapy After an Acute Nonminor Stroke.

Downey J, Blackwell S, Germain K, Pinner NA, Starr JA. Downey J, et al. Among authors: starr ja. J Pharm Technol. 2023 Apr;39(2):51-54. doi: 10.1177/87551225221145836. Epub 2023 Jan 22. J Pharm Technol. 2023. PMID: 37051285 Free PMC article.

9

SGLT2 Inhibitors to Slow Chronic Kidney Disease Progression: A Review.

Maxson R, Starr J, Sewell J, Lyas C. Maxson R, et al. Clin Ther. 2024 Jan;46(1):e23-e28. doi: 10.1016/j.clinthera.2023.10.014. Epub 2023 Nov 10. Clin Ther. 2024. PMID: 37951783 Review.

10

Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism in Obesity.

Hattaway Q, Starr JA, Pinner NA. Hattaway Q, et al. Among authors: starr ja. J Pharm Technol. 2023 Dec;39(6):269-273. doi: 10.1177/87551225231196748. Epub 2023 Sep 4. J Pharm Technol. 2023. PMID: 37974596 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters